Marcos Perez

Sanofi (Germany)

Papers (4)

• 2023
  Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment.10.3389/fmicb.2023.1127321
• 2023
  Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.10.1007/s40272-022-00536-9
• 2022
  Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.10.1007/s12325-022-02285-0
• 2022
  Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence10.1080/1744666X.2022.2085559